The DOI matches its Crossref record; 149 of the 149 references it cites were found in a registry or an index.
C-Reactive Protein and Cancer—Diagnostic and Therapeutic Insights
Open accessAbstract
Cancer disease describes any pathology involving uncontrolled cell growth. As cells duplicate, they can remain localized in defined tissues, forming tumor masses and altering their microenvironmental niche, or they can disseminate throughout the body in a metastatic process affecting multiple tissues and organs. As tumors grow and metastasize, they affect normal tissue integrity and homeostasis which signals the body to trigger the acute phase inflammatory response. C-reactive protein (CRP) is a predominant protein of the acute phase response; its blood levels have long been used as a minimally invasive index of any ongoing inflammatory response, including that occurring in cancer. Its diagnostic significance in assessing disease progression or remission, however, remains undefined. By considering the recent understanding that CRP exists in multiple isoforms with distinct biological activities, a unified model is advanced that describes the relevance of CRP as a mediator of host defense responses in cancer. CRP in its monomeric, modified isoform (mCRP) modulates inflammatory responses by inserting into activated cell membranes and stimulating platelet and leukocyte responses associated with acute phase responses to tumor growth. It also binds components of the extracellular matrix in involved tissues. Conversely, CRP in its pentameric isoform (pCRP), which is the form quantified in diagnostic measurements of CRP, is notably less bioactive with weak anti-inflammatory bioactivity. Its accumulation in blood is associated with a continuous, low-level inflammatory response and is indicative of unresolved and advancing disease, as occurs in cancer. Herein, a novel interpretation of the diagnostic utility of CRP is presented accounting for the unique properties of the CRP isoforms in the context of the developing pro-metastatic tumor microenvironment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Coussens, L. M., & Werb, Z. (2002) · Nature · doi:10.1038/nature01322 · Cited by 15,111
Immunity, Inflammation, and Cancer
Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755
Inflammation and cancer: back to Virchow?
Balkwill, F., & Mantovani, A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04046-0 · Cited by 7,746
Factors affecting wound healing
Guo, S., & DiPietro, L. A. (2010) · Journal of Dental Research · doi:10.1177/0022034509359125 · Cited by 5,792
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Tumor mutational burden and response rate to PD-1 inhibition
Yarchoan, M., Hopkins, A., & Jaffee, E. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1713444 · Cited by 3,230
U.S. Department of Health and Human Services
(2006) · Encyclopedia of Sexual Behavior and the Law · doi:10.4135/9781452240107.n226 · Cited by 3,170
Role of C-Reactive Protein at Sites of Inflammation and Infection
Sproston, N. R., & Ashworth, J. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00754 · Cited by 3,029
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
TGF-β-induced epithelial to mesenchymal transition
Xu, J., Lamouille, S., & Derynck, R. (2009) · Cell Research · doi:10.1038/cr.2009.5 · Cited by 2,804
Allemani, C., Weir, H. K., Carreira, H., Harewood, R., Spika, D., Wang, X.-S., Bannon, F., Ahn, J. V., Johnson, C. J., Bonaventure, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(14)62038-9 · Cited by 2,614
Roles of the immune system in cancer: From tumor initiation to metastatic progression
Gonzalez, H., Hagerling, C., & Werb, Z. (2018) · Genes & Development · doi:10.1101/gad.314617.118 · Cited by 2,111
The tumor microenvironment at a glance
Balkwill, F. R., Capasso, M., & Hagemann, T. (2012) · Journal of Cell Science · doi:10.1242/jcs.116392 · Cited by 1,857
Chronic inflammation and cytokines in the tumor microenvironment
Landskron, G., De la Fuente, M., Thuwajit, P., Thuwajit, C., & Hermoso, M. A. (2014) · Journal of Immunology Research · doi:10.1155/2014/149185 · Cited by 1,765
CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - a target for novel cancer therapy
Tokunaga, R., Zhang, W., Naseem, M., Puccini, A., Berger, M. D., Soni, S., McSkane, M., Baba, H., & Lenz, H.-J. (2018) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2017.11.007 · Cited by 1,627
Wound healing - A literature review
Gonzalez, A. C. D. O., Costa, T. F., Andrade, Z. D. A., & Medrado, A. R. A. P. (2016) · Anais Brasileiros de Dermatologia · doi:10.1590/abd1806-4841.20164741 · Cited by 1,605
Lin, Y., Xu, J., & Lan, H. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0760-3 · Cited by 1,398
Cold Tumors: A Therapeutic Challenge for Immunotherapy
Bonaventura, P., Shekarian, T., Alcazer, V., Valladeau-Guilemond, J., Valsesia-Wittmann, S., Amigorena, S., Caux, C., & Depil, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00168 · Cited by 1,108
Fibroblasts and myofibroblasts in wound healing
Desmouliere, A., Darby, I. A., Laverdet, B., & Bonté, F. (2014) · Clinical, Cosmetic and Investigational Dermatology · doi:10.2147/ccid.s50046 · Cited by 1,039
Human C-reactive protein: expression, structure, and function
Volanakis, J. (2001) · Molecular Immunology · doi:10.1016/s0161-5890(01)00042-6 · Cited by 926
The physiological structure of human C-reactive protein and its complex with phosphocholine
Thompson, D., Pepys, M. B., & Wood, S. P. (1999) · Structure · doi:10.1016/s0969-2126(99)80023-9 · Cited by 818
Biology of the Extracellular Matrix: An Overview
Yue, B. (2014) · Journal of Glaucoma · doi:10.1097/ijg.0000000000000108 · Cited by 805
Shaw, T. J., & Martin, P. (2009) · Journal of Cell Science · doi:10.1242/jcs.031187 · Cited by 765
Modes of cancer cell invasion and the role of the microenvironment
Clark, A. G., & Vignjevic, D. M. (2015) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2015.06.004 · Cited by 761
How Do Cytotoxic Lymphocytes Kill Cancer Cells?
Martínez-Lostao, L., Anel, A., & Pardo, J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-0685 · Cited by 717
Cancer-related inflammation: Common themes and therapeutic opportunities
Balkwill, F. R., & Mantovani, A. (2012) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.005 · Cited by 685
Fiori, M. E., Di Franco, S., Villanova, L., Bianca, P., Stassi, G., & De Maria, R. (2019) · Molecular Cancer · doi:10.1186/s12943-019-0994-2 · Cited by 647
Murata, M. (2018) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-018-0740-1 · Cited by 588
Epithelial-mesenchymal transition in tissue repair and fibrosis
Stone, R. C., Pastar, I., Ojeh, N., Chen, V., Liu, S., Garzon, K. I., & Tomic-Canic, M. (2016) · Cell and Tissue Research · doi:10.1007/s00441-016-2464-0 · Cited by 572
EMT and inflammation: inseparable actors of cancer progression
Suarez‐Carmona, M., Lesage, J., Cataldo, D., & Gilles, C. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12095 · Cited by 566
C‐reactive protein correlates with computed tomographic findings and predicts severe COVID‐19 early
Tan, C., Huang, Y., Shi, F., Tan, K., Ma, Q., Chen, Y., Jiang, X., & Li, X. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25871 · Cited by 565
C-Reactive Protein and the Risk of Incident Colorectal Cancer
Erlinger, T. P. (2004) · JAMA · doi:10.1001/jama.291.5.585 · Cited by 533
Damsky, C. H., & Werb, Z. (1992) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(92)90100-q · Cited by 518
Mack, M. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.11.010 · Cited by 514
Targeting the CCL2-CCR2 signaling axis in cancer metastasis
Lim, S. Y., Yuzhalin, A. E., Gordon-Weeks, A. N., & Muschel, R. J. (2016) · Oncotarget · doi:10.18632/oncotarget.7376 · Cited by 501
Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment
Liu, T., Zhou, L., Li, D., Andl, T., & Zhang, Y. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00060 · Cited by 446
Dissecting the mechanisms of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0275-8 · Cited by 434
Autocrine PDGFR signaling promotes mammary cancer metastasis
Jechlinger, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci24652 · Cited by 371
At the Bench: Preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
Intlekofer, A. M., & Thompson, C. B. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.1212621 · Cited by 371
Structure and biological activity of the extracellular matrix
Aumailley, M., & Gayraud, B. (1998) · Journal of Molecular Medicine · doi:10.1007/s001090050215 · Cited by 369
Three dimensional structure of human C-reactive protein
Shrive, A. K., Gheetham, G. M. T., Holden, D., Myles, D. A. A., Turnell, W. G., Volanakis, J. E., Pepys, M. B., Bloomer, A. C., & Greenhough, T. J. (1996) · Nature Structural & Molecular Biology · doi:10.1038/nsb0496-346 · Cited by 356
Targeting Inflammation in Cancer Prevention and Therapy
Todoric, J., Antonucci, L., & Karin, M. (2016) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-16-0209 · Cited by 354
Cancer associated fibroblasts: An essential role in the tumor microenvironment
Tao, L., Huang, G., Song, H., Chen, Y., & Chen, L. (2017) · Oncology Letters · doi:10.3892/ol.2017.6497 · Cited by 351
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis
Neel, J.-C., Humbert, L., & Lebrun, J.-J. (2012) · ISRN Molecular Biology · doi:10.5402/2012/381428 · Cited by 345
Jung, H.-Y., Fattet, L., & Yang, J. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-3173 · Cited by 309
Masjedi, A., Hashemi, V., Hojjat-Farsangi, M., Ghalamfarsa, G., Azizi, G., Yousefi, M., & Jadidi-Niaragh, F. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.177 · Cited by 303
C-reactive protein and inflammation: conformational changes affect function
Wu, Y., Potempa, L. A., El Kebir, D., & Filep, J. G. (2015) · Biological Chemistry · doi:10.1515/hsz-2015-0149 · Cited by 285
Self-citationTumors and Fibrinogen: The Role of Fibrinogen as an Extracellular Matrix Protein
SIMPSON‐HAIDARIS, P. J., & RYBARCZYK, B. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb03525.x · Cited by 284
Function of proteoglycans in the extracellular matrix
Yanagishita, M. (1993) · Acta Pathologica Japonica · doi:10.1111/j.1440-1827.1993.tb02569.x · Cited by 276
Shrotriya, S., Walsh, D., Bennani-Baiti, N., Thomas, S., & Lorton, C. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143080 · Cited by 274
Lippitz, B. E., & Harris, R. A. (2016) · OncoImmunology · doi:10.1080/2162402x.2015.1093722 · Cited by 248
Transmembrane molecular assemblies in cell-extracellular matrix interactions
Turner, C. E., & Burridge, K. (1991) · Current Opinion in Cell Biology · doi:10.1016/0955-0674(91)90059-8 · Cited by 236
Extracellular matrix, supramolecular organisation and shape.
Scott, J. E. (1995) · PubMed Central · Cited by 235
EMT and Oxidative Stress: A Bidirectional Interplay Affecting Tumor Malignancy
Giannoni, E., Parri, M., & Chiarugi, P. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4280 · Cited by 231
Acute Phase Proteins in Animals
Cray, C. (2012) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-394596-9.00005-6 · Cited by 220
C-Reactive Protein and Risk of Lung Cancer
Chaturvedi, A. K., Caporaso, N. E., Katki, H. A., Wong, H.-L., Chatterjee, N., Pine, S. R., Chanock, S. J., Goedert, J. J., & Engels, E. A. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.0454 · Cited by 217
Transitional changes in the CRP structure lead to the exposure of proinflammatory binding sites
Braig, D., Nero, T. L., Koch, H.-G., Kaiser, B., Wang, X., Thiele, J. R., Morton, C. J., Zeller, J., Kiefer, J., Potempa, L. A., et al. (2017) · Nature Communications · doi:10.1038/ncomms14188 · Cited by 205
Self-citationSerum C-Reactive Protein as Independent Prognostic Variable in Patients with Ovarian Cancer
Hefler, L. A., Concin, N., Hofstetter, G., Marth, C., Mustea, A., Sehouli, J., Zeillinger, R., Leipold, H., Lass, H., Grimm, C., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1044 · Cited by 199
The role of IL-1B in breast cancer bone metastasis
Tulotta, C., & Ottewell, P. (2018) · Endocrine-Related Cancer · doi:10.1530/erc-17-0309 · Cited by 191
McFadyen, J. D., Kiefer, J., Braig, D., Loseff-Silver, J., Potempa, L. A., Eisenhardt, S. U., & Peter, K. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01351 · Cited by 181
Self-citationDrake, J. M., Strohbehn, G., Bair, T. B., Moreland, J. G., & Henry, M. D. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-10-1076 · Cited by 177
Basic Principles of Wound Healing
HUNT, T. K. (1990) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/00005373-199012001-00025 · Cited by 167
Fibronectin: How Its Aberrant Expression in Tumors May Improve Therapeutic Targeting
Wang, J. P., & Hielscher, A. (2017) · Journal of Cancer · doi:10.7150/jca.16901 · Cited by 167
Epithelial-mesenchymal transition and inflammation at the site of the primary tumor
Dominguez, C., David, J. M., & Palena, C. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.08.002 · Cited by 162
C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis
Zhou, B., Shu, B., Yang, J., Liu, J., Xi, T., & Xing, Y. (2014) · Cancer Causes & Control · doi:10.1007/s10552-014-0445-8 · Cited by 155
Allin, K. H., Nordestgaard, B. G., Flyger, H. L., & Bojesen, S. E. (2011) · Breast Cancer Research · doi:10.1186/bcr2891 · Cited by 152
How C-Reactive Protein Structural Isoforms With Distinctive Bioactivities Affect Disease Progression
Rajab, I. M., Hart, P. C., & Potempa, L. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02126 · Cited by 143
Self-citationThe prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer
Liu, Y., Chen, S., Zheng, C., Ding, M., Zhang, L., Wang, L., Xie, M., & Zhou, J. (2017) · BMC Cancer · doi:10.1186/s12885-017-3220-x · Cited by 140
C-reactive protein and risk of breast cancer: A systematic review and meta-analysis
Guo, L., Liu, S., Zhang, S., Chen, Q., Zhang, M., Quan, P., Lu, J.-B., & Sun, X. (2015) · Scientific Reports · doi:10.1038/srep10508 · Cited by 132
Biological and clinical relevance of Laminin-5 in cancer
Giannelli, G., & Antonaci, S. (2000) · Clinical & Experimental Metastasis · doi:10.1023/a:1011879900554 · Cited by 126
Aleksandrova, K., Jenab, M., Boeing, H., Jansen, E. H. J. M., Bueno-de-Mesquita, H. B., Rinaldi, S., Ríboli, E., Overvad, K., Dahm, C. C., Olsen, A., et al. (2010) · American Journal of Epidemiology · doi:10.1093/aje/kwq135 · Cited by 125
Binding of fibronectin by the acute phase reactant C-reactive protein.
Salonen, E., VARTIO, T., Hedman, K., et al. (1984) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)43435-1 · Cited by 117
Song, W., Mazzieri, R., Yang, T., & Gobe, G. C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01106 · Cited by 112
Targeting C‐Reactive Protein in Inflammatory Disease by Preventing Conformational Changes
Thiele, J. R., Zeller, J., Bannasch, H., Stark, G. B., Peter, K., & Eisenhardt, S. U. (2015) · Mediators of Inflammation · doi:10.1155/2015/372432 · Cited by 109
Potempa, L. A., Rajab, I. M., Hart, P. C., Bordón, J., & Fernandez-Botrán, R. (2020) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.20-0473 · Cited by 106
Self-citationKoch, A., Fohlin, H., & Sörenson, S. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31819578c8 · Cited by 104
C-Reactive Protein and Risk of Breast Cancer
Zhang, S. M., Lin, J., Cook, N. R., Lee, I.-M. M., Manson, J. E., Buring, J. E., & Ridker, P. M. (2007) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djk202 · Cited by 99
Shrotriya, S., Walsh, D., Nowacki, A. S., Lorton, C. M., Aktaş, A., Hullihen, B., Benanni-Baiti, N., Hauser, K., Ayvaz, S., & Estfan, B. N. (2018) · PLoS ONE · doi:10.1371/journal.pone.0202555 · Cited by 99
Stevens, L. G., Pathak, S., Nunes, Q. M., Pandanaboyana, S., Macutkiewicz, C., Smart, N. J., & Smith, A. M. (2014) · HPB · doi:10.1111/hpb.12355 · Cited by 96
Tomita, M., Shimizu, T. M., Ayabe, T., Nakamura, K., & Onitsuka, T. (2012) · PubMed · Cited by 96
Preoperative serum C-reactive protein level in non-small cell lung cancer.
Hara, M., Matsuzaki, Y., Shimuzu, T., Tomita, M., Ayabe, T., Enomoto, Y., & Onitsuka, T. (2007) · PubMed · Cited by 92
Macrophage Polarization and Its Role in Cancer
Smith, E. W. C. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000338 · Cited by 92
Postdiagnosis C-Reactive Protein and Breast Cancer Survivorship: Findings from the WHEL Study
Villaseñor, A., Flatt, S. W., Marinac, C., Natarajan, L., Pierce, J. P., & Patterson, R. E. (2014) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0852 · Cited by 89
Systematic Review and Meta-Analysis on the Association between IL-1B Polymorphisms and Cancer Risk
Xu, J., Yin, Z., Cao, S., Gao, W., Liu, L., Yin, Y., Liu, P., & Shu, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063654 · Cited by 89
Nimptsch, K., Aleksandrova, K., Boeing, H., Janke, J., Lee, Y., Jenab, M., Bueno-de-Mesquita, H. B., Jansen, E. H. J. M., Tsilidis, K. K., Trichopoulou, A., et al. (2014) · International Journal of Cancer · doi:10.1002/ijc.29086 · Cited by 87
C-Reactive Protein As a Marker of Melanoma Progression
Fang, S., Wang, Y., Sui, D., Liu, H., Ross, M. I., Gershenwald, J. E., Cormier, J. N., Royal, R. E., Lucci, A., Schacherer, C. W., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.0209 · Cited by 87
Cao, B., Bray, F., Beltrán‐Sánchez, H., Ginsburg, O., Soneji, S. S., & Soerjomataram, I. (2017) · BMJ · doi:10.1136/bmj.j2765 · Cited by 81
Liao, C., Yu, Z., Guo, W., Liu, Q., Wu, Y., Li, Y., & Bai, L. (2014) · Cancer Biomarkers · doi:10.3233/cbm-140423 · Cited by 80
He, X., Li, J.-P., Liu, X., Zhang, J., Zeng, Q., Chen, H., & Chen, S. (2018) · Journal of Cancer · doi:10.7150/jca.23320 · Cited by 80
Gu, X., Zheng, R., Xia, C., Zeng, H., Zhang, S., Zou, X., Yang, Z., He, L., & Chen, W. (2018) · 癌症:英文版 · doi:10.1186/s40880-018-0308-x · Cited by 78
An ELISA Assay for Quantifying Monomeric C-Reactive Protein in Plasma
Zhang, L., Li, H., Li, W., Shen, Z.-Y., Wang, Y.-D., Ji, S., & Wu, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00511 · Cited by 75
Alifano, M., Falcoz, P., Seegers, V., Roche, N., Schussler, O., Younes, M., Antonacci, F., Forgez, P., Dechartres, A., Massard, G., et al. (2011) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.07.021 · Cited by 74
Thiele, J. R., Zeller, J., Kiefer, J., Braig, D., Kreuzaler, S., Lenz, Y., Potempa, L. A., Grahammer, F., Huber, T. B., Huber-Lang, M. S., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00675 · Cited by 73
Self-citationPlasma C-Reactive Protein and Risk of Breast Cancer in Two Prospective Studies and a Meta-analysis
Wang, J., Lee, I.-M. M., Tworoger, S. S., Buring, J. E., Ridker, P. M., ROSNER, B. A., & Hankinson, S. E. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0187 · Cited by 67
An Intrinsically Disordered Motif Mediates Diverse Actions of Monomeric C-reactive Protein
Li, H., Wang, J., Meng, F., Jia, Z.-K., Su, Y., Bai, Q., Lv, L., Ma, F., Potempa, L. A., Yan, Y., et al. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.695023 · Cited by 67
Self-citationMuller, D. C., Larose, T. L., Hodge, A. M., Guida, F., Langhammer, A., Grankvist, K., Meyer, K., Cai, Q., Arslan, A. A., Zeleniuch‐Jacquotte, A., et al. (2019) · BMJ · doi:10.1136/bmj.k4981 · Cited by 67
Troppan, K. T., Schlick, K., Deutsch, A. J. A., Melchardt, T., Egle, A., Stojaković, T., Beham‐Schmid, C., Weiss, L., Neureiter, D., Wenzl, K., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.277 · Cited by 66
Thomson, C. A., Thompson, P. A., Bea, J. W., Nardi, E., Frey, G., & Stopeck, A. (2009) · Journal of Women s Health · doi:10.1089/jwh.2009.1365 · Cited by 63
Guo, S., He, X., Chen, Q., Yang, G., Yao, K. T., Dong, P., Ye, Y., Chen, D., Zhang, Z., Qin, Z., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3119-6 · Cited by 63
Gathirua‐Mwangi, W. G., Song, Y., Monahan, P. O., Champion, V. L., & Zollinger, T. W. (2018) · International Journal of Cancer · doi:10.1002/ijc.31344 · Cited by 63
Thurner, E.-M., Krenn-Pilko, S., Langsenlehner, U., Stojaković, T., Pichler, M., Gerger, A., Kapp, K. S., & Langsenlehner, T. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.01.002 · Cited by 61
Prognostic role of C-reactive protein in prostate cancer: a systematic review and meta-analysis
Xu, Q., Liu, Z., Chu, L., Fang, J., Zhang, X., Zhao, H.-X., & Chen, Y. (2014) · Asian Journal of Andrology · doi:10.4103/1008-682x.123686 · Cited by 59
Neri, S., Miyashita, T., Hashimoto, H., Suda, Y., Ishibashi, M., Kii, H., Watanabe, H., Kuwata, T., Tsuboi, M., Goto, K., et al. (2017) · Cancer Letters · doi:10.1016/j.canlet.2017.02.026 · Cited by 59
Shishido, Y., Fujitani, K., Yamamoto, K., Hirao, M., Tsujinaka, T., & Sekimoto, M. (2015) · Gastric Cancer · doi:10.1007/s10120-014-0455-y · Cited by 55
Li, H., Wang, J., Wu, Y., Zhang, L., Liu, Z.-P., Filep, J. G., Potempa, L. A., Wu, Y., & Ji, S. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.555318 · Cited by 52
Self-citationBaseline and postoperative C-reactive protein levels predict mortality in operable lung cancer
Pastorino, U., Morelli, D., Leuzzi, G., Gisabella, M., Suatoni, P., Taverna, F., Bertocchi, E., Boeri, M., Sozzi, G., Cantarutti, A., et al. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2017.03.020 · Cited by 52
Redox (phospho)lipidomics of signaling in inflammation and programmed cell death
Tyurina, Y. Y., Croix, C. M. S., Watkins, S. C., Watson, A. M., Epperly, M. W., Anthonymuthu, T. S., Kisin, E. R., Vlasova, I. I., Krysko, O., Krysko, D. V., et al. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0119-004rr · Cited by 49
Platz, E. A., Marzo, A. M. D., Erlinger, T. P., Rifai, N., Visvanathan, K., Hoffman, S. C., & Helzlsouer, K. J. (2003) · The Prostate · doi:10.1002/pros.10368 · Cited by 48
C-Reactive Protein and Colorectal Cancer Mortality in U.S. Adults
Goyal, A., Terry, M. B., Jin, Z., & Siegel, A. B. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0577 · Cited by 47
Progression of Airway Dysplasia and C-Reactive Protein in Smokers at High Risk of Lung Cancer
Sin, D. D., Man, S. F. P., McWilliams, A. M., & Lam, S. C. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200508-1305oc · Cited by 46
Birk, D. E., Silver, F. H., & Trelstad, R. L. (1991) · Springer eBooks · doi:10.1007/978-1-4615-3770-0_8 · Cited by 45
Extracellular matrix analogs as carriers for growth factors: In vitro fibroblast behavior
Roy, F., DeBlois, C., & Doillon, C. J. (1993) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820270312 · Cited by 44
Dai, J. M., Tang, K., Xiao, W., Yu, G., Zeng, J., Li, W., Zhang, Y., Xu, H., Chen, Z., & Ye, Z. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.8.3369 · Cited by 43
Prognostic Influence of Pre-Operative C-Reactive Protein in Node-Negative Breast Cancer Patients
Sicking, I., Edlund, K., Wesbuer, E., Weyer, V., Battista, M. J., Lebrecht, A., Solbach, C., Grinberg, M., Lotz, J., Hoffmann, G. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111306 · Cited by 42
Oliveira, K. G., von Zeidler, S. V., Lamas, A. Z., de Podestá, J. R. V., Sena, A., Souza, E. D., Lenzi, J., Lemos, E. M., Gouvêa, S. A., & Bissoli, N. S. (2014) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20143599 · Cited by 41
Enhancing Cancer Immunotherapy Via Activation of Innate Immunity
Goldberg, J. L., & Sondel, P. M. (2015) · Seminars in Oncology · doi:10.1053/j.seminoncol.2015.05.012 · Cited by 40
Fang, Y., Xu, C. Q., Wu, P., Zhang, L.-H., Li, D., Sun, J., Li, W., & Liao, Z. (2017) · Medicine · doi:10.1097/md.0000000000008463 · Cited by 40
Tseng, J., & Mortensen, R. F. (1988) · Molecular Immunology · doi:10.1016/0161-5890(88)90103-4 · Cited by 38
C-reactive protein is a potential prognostic factor for metastatic gastric cancer.
Shimura, T., Kitagawa, M., Yamada, T., et al. (2012) · PubMed · Cited by 38
Zhang, L., Shen, Z., Wang, K., Li, W., Shi, J., Osoro, E. K., Ullah, N., Zhou, Y., & Ji, S. (2019) · The FASEB Journal · doi:10.1096/fj.201801865rr · Cited by 38
CRP evaluation in non-small cell lung cancer
Aref, H., & Refaat, S. (2014) · Egyptian Journal of Chest Diseases and Tuberculosis · doi:10.1016/j.ejcdt.2014.02.003 · Cited by 36
C-reactive protein and risk of ovarian cancer
Li, J., Jiao, X., Yuan, Z., Qiu, H., & Guo, R. (2017) · Medicine · doi:10.1097/md.0000000000007822 · Cited by 36
Holm, M., Saraswat, M., Joenväärä, S., Ristimaki, A. P., Haglund, C. H., & Renkonen, R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195354 · Cited by 36
Omae, K., Kondo, T., & Tanabe, K. (2014) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2014.07.004 · Cited by 34
Effects of Extracellular Matrix Components on Cell Locomotion
McCarthy, J. B., & Turley, E. A. (1993) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411930040050101 · Cited by 34
The Role of C-reactive Protein in Innate and Acquired Inflammation: New Perspectives
Trial, J., Potempa, L. A., & Entman, M. L. (2016) · Inflammation and Cell Signaling · doi:10.14800/ics.1409 · Cited by 33
Self-citationC-reactive protein in gallbladder diseases: diagnostic and therapeutic insights
Rajab, I. M., Majerczyk, D., Olson, M. E., Addams, J. M. B., Choe, M. L., Nelson, M. S., & Potempa, L. A. (2020) · Biophysics Reports · doi:10.1007/s41048-020-00108-9 · Cited by 33
Self-citationRodriguez‐Gil, J. L., Takita, C., Wright, J. L., dos Reis, I. M., Zhao, W. K., Lally, B. E., & Hu, J. J. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-0263 · Cited by 32
Nelson, S. H., Brasky, T. M., Patterson, R. E., Laughlin, G. A., Kritz‐Silverstein, D. C., Edwards, B. J.-A., Lane, D. S., Rohan, T. E., Ho, G. Y. F., Manson, J. E., et al. (2017) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-16-1005 · Cited by 31
The patient burden of opioidinduced bowel dysfunction
Hyldahl, S., Gronlund, D., Drewes, A. M., & Brock, C. (2018) · Clinical Practice · doi:10.4172/clinical-practice.1000409 · Cited by 31
C-reactive protein as a significant prognostic factor for stage IV gastric cancer patients.
Baba, H., Kuwabara, K., Ishiguro, T., Hatano, S., Matsuzawa, T., Fukuchi, M., Kumagai, Y., Ishibashi, K., Mochiki, E., & Ishida, H. (2013) · PubMed · Cited by 30
Characteristics of the binding of human C‐reactive protein (CRP) to laminin
Swanson, S. J., McPeek, M., & Mortensen, R. F. (1989) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240400112 · Cited by 30
Xu, L., Zhao, Q., Huang, S., Li, S., Wang, J., & Li, Q. (2014) · Tumor Biology · doi:10.1007/s13277-014-2670-x · Cited by 29
Signal transduction in wound pharmacology
Kim, W. J. H., Gittes, G. K., & Longaker, M. T. (1998) · Archives of Pharmacal Research · doi:10.1007/bf02975363 · Cited by 29
Katano, A., Takahashi, W., Yamashita, H., Yamamoto, K., Ando, M., Yoshida, M., Saito, Y., Abe, O., & Nakagawa, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-18233-w · Cited by 29
Wang, X., Liu, S., Zhao, X., Fang, E., & Zhao, X. (2019) · PLoS ONE · doi:10.1371/journal.pone.0219215 · Cited by 28
Monomeric C-reactive protein regulates fibronectin mediated monocyte adhesion
Ullah, N., Ma, F.-R., Han, J., Liu, X., Fu, Y., Liu, Y.-T., Liang, Y., Ouyang, H., & Li, H. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.10.013 · Cited by 28
Localized translation regulates cell adhesion and transendothelial migration
Bergeman, J., Caillier, A., Houle, F., Gagné, L. M., & Huot, M. (2016) · Journal of Cell Science · doi:10.1242/jcs.191320 · Cited by 26
Szturmowicz, M., Rudzinski, P. M., Kacprzak, A., Langfort, R., Bestry, I., Broniarek-Samson, B., & Orlowski, T. M. (2014) · Advances in respiratory medicine · doi:10.5603/piap.2014.0055 · Cited by 25
Prognostic value of C-reactive protein levels in patients with bone neoplasms: A meta-analysis
Li, W., Luo, X., Liu, Z., Chen, Y., & Li, Z. (2018) · PLoS ONE · doi:10.1371/journal.pone.0195769 · Cited by 22
Fang, E., Wang, X., Feng, J., & Zhao, X. (2020) · Disease Markers · doi:10.1155/2020/8736509 · Cited by 19
Bittoni, M. A., Focht, B. C., Clinton, S. K., Buckworth, J., & Harris, R. E. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3141 · Cited by 17
Kinoshita, A., Onoda, H., Imai, N., Iwaku, A., Oishi, M., Tanaka, K., Fushiya, N., Koike, K., Nishino, H., Matsushima, M., et al. (2014) · Oncology · doi:10.1159/000360704 · Cited by 14
C-reactive protein is associated with the development of tongue squamous cell carcinoma
Du, J., Hu, W., Yang, C., Wang, Y., Wang, X., & Yang, P.-S. (2018) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmy004 · Cited by 14
Changes in physical activity behavior and C-reactive protein in breast cancer patients
Sabiston, C. M., Wrosch, C., Castonguay, A. L., & Sylvester, B. D. (2018) · Annals of Behavioral Medicine · doi:10.1093/abm/kax010 · Cited by 14
Nakai, K., Tanaka, H., Yamanaka, K., Takahashi, Y., Murakami, F., Matsuike, R., Sekino, J., Tanabe, N., Morita, T., Yamazaki, Y., et al. (2017) · International Journal of Medical Sciences · doi:10.7150/ijms.18059 · Cited by 13
Lumachi, F., Basso, S. M. M., Santeufemia, D. A., Ermani, M., Re, G. L., & Chiara, G. B. (2014) · PubMed · Cited by 9
C-reactive protein gene rs1205 polymorphism is not associated with the risk of colorectal cancer
Fang, D., & Ye, Y. (2017) · Bioscience Reports · doi:10.1042/bsr20170872 · Cited by 8
Cited by
C-reactive protein: structure, function, regulation, and role in clinical diseases
Zhou, H.-H., Tang, Y.-L., Xu, T.-H., & Cheng, B. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1425168 · Cited by 162
Na, H., Yang, J. B., Zhang, Z., Gan, Q., Tian, H., Rajab, I. M., Potempa, L. A., Tao, Q., & Qiu, W. Q. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.02.013 · Cited by 27
Self-citationVisovatti, M. A., Jung, M. S., & Von Ah, D. (2026) · Cancer Nursing · doi:10.1097/ncc.0000000000001473 · Cited by 2
Metadata
- Authors
- Hart, P. C., Rajab, I. M., Alebraheem, M., & Potempa, L. A.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2020-11-19
- Volume
- 11
- Pages
- 595835-595835
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W3108008028
- Cited by
- 275
- References
- 149
- FWCI
- 7.95
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.